Analysts from leading investment firms have recently revised their outlooks on several prominent companies. Among the notable changes, Goldman Sachs upgraded Microsoft and raised its price target, while Mizuho downgraded Intel and lowered its price target. These analyst ratings can significantly impact investor sentiment and stock performance.
Amidst market volatility, dividend-yielding stocks offer stability for investors. Here are three financial stocks with high yields and the latest analyst ratings from some of the most accurate analysts in the industry. These ratings provide valuable insights for traders and investors seeking income-generating opportunities.
Top Wall Street analysts have adjusted their price targets and ratings for several notable companies. Here’s a summary of the changes:
– Susquehanna raised its target for Impinj, Inc. (PI) from $130 to $140, maintaining a ‘Positive’ rating.
– HSBC lowered its target for Intel Corporation (INTC) from $44 to $37, maintaining a ‘Hold’ rating.
– Piper Sandler cut its target for Chewy, Inc. (CHWY) from $19 to $16, maintaining a ‘Neutral’ rating.
– B of A Securities reduced its target for Vertex, Inc. (VERX) from $40 to $34, maintaining a ‘Neutral’ rating.
– Mizuho lowered its target for Marriott International, Inc. (MAR) from $263 to $260, maintaining a ‘Neutral’ rating.
– BMO Capital raised its target for Amazon.com, Inc. (AMZN) from $205 to $215, maintaining an ‘Outperform’ rating.
– Baird cut its target for Simpson Manufacturing Co., Inc. (SSD) from $215 to $208, maintaining an ‘Outperform’ rating.
– Oppenheimer increased its target for Church & Dwight Co., Inc. (CHD) from $110 to $120, maintaining an ‘Outperform’ rating.
– RBC Capital boosted its target for Zions Bancorporation (ZION) from $46 to $47, maintaining a ‘Sector Perform’ rating.
– JP Morgan upgraded Roblox Corporation (RBLX) from ‘Neutral’ to ‘Overweight’ and raised its target from $41 to $48.
Food and beverage giant PepsiCo (PEP) is expected to report its first-quarter financial results before the market opens on Tuesday. Analysts estimate the company will report revenue of $18.08 billion and earnings per share of $1.52, representing modest growth compared to the previous year’s first quarter. While Pepsi has consistently surpassed expectations in recent quarters, analysts warn that a Quaker recall and a slowdown in salty snacks could impact the results. Despite these concerns, analysts remain bullish on Pepsi’s long-term prospects, citing its international growth and strong brands.
Lucid Group (LCID) has received mixed analyst ratings, ranging from bearish to bullish. In the last 30 days, 5 analysts have rated the stock as indifferent, 2 as somewhat bearish, and 0 as bullish or somewhat bullish. The average 12-month price target is $3.63, with a high estimate of $4.50 and a low estimate of $2.90. Analysts have decreased the average price target by 34.0% from a month ago.
Gentherm’s (THRM) analyst ratings over the past quarter have varied from bullish to bearish, with 0 bullish, 0 somewhat bullish, 1 indifferent, 3 somewhat bearish, and 0 bearish ratings. Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $61.75, a high estimate of $66.00, and a low estimate of $58.00. This current average reflects an increase of 2.92% from the previous average price target of $60.00.
Analysts have recently provided 12-month price targets for EOG Resources EOG, with the average target set at $146.00. The current average reflects a 0.32% increase from the previous average price target of $145.53, indicating an upward trend. Bullish ratings have increased from 2 to 5 in the last 30 days, while bearish ratings remain at 0. In the past 3 months, 20 analysts have published ratings on EOG, revealing a shifting sentiment over the past 30 days. This news provides insights into the perception of EOG Resources by financial experts and can be valuable for investors seeking to understand consensus views on the stock’s potential future performance.
Analysts have provided a mix of bullish and bearish perspectives on Monday.Com (MNDY) in the past three months. The average price target for the next 12 months is $246.15, with a high estimate of $280.00 and a low estimate of $190.00. Key insights from analysts include: David Hynes of Canaccord Genuity lowered his rating from Buy to Neutral, while Michael Berg of Wells Fargo initiated coverage with an Overweight rating. Jason Celino of Keybanc raised his price target twice, indicating growing confidence in the company’s prospects.
Analysts have provided diverse ratings for Glacier Bancorp in the past three months. Four analysts have issued ratings, with a mix of bullish and bearish perspectives. The average 12-month price target is $42.75, with a high estimate of $45.00 and a low estimate of $40.00. Glacier Bancorp’s revenue growth has faced challenges, while its net margin remains strong. The company’s ROE and ROA are below industry averages, and its debt-to-equity ratio is above industry norms.
Analysts have provided a range of perspectives on Kymera Therapeutics, with some expressing optimism while others remain cautious. The average price target has increased to $53.0, indicating a positive outlook for the company’s future performance.
